|
4
|
Feldman G, Li M, Martin S, Urbanek M, Urtizberea JA, Fardeau M, LeMerrer M, Connor JM, Triffitt J, Smith R, Muenke M, Kaplan FS, Shore EM. Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. Am J Hum Genet 2000; 66:128-35. [PMID: 10631143 PMCID: PMC1288317 DOI: 10.1086/302724] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/1999] [Accepted: 10/13/1999] [Indexed: 11/03/2022] Open
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a severely disabling, autosomal-dominant disorder of connective tissue and is characterized by postnatal progressive heterotopic ossification of muscle, tendon, ligament, and fascia and by congenital malformation of the great toes. To identify the chromosomal location of the FOP gene, we conducted a genomewide linkage analysis, using four affected families with a total of 14 informative meioses. Male-to-male transmission of the FOP phenotype excluded X-linked inheritance. Highly polymorphic microsatellite markers covering all human autosomes were amplified by use of PCR. The FOP phenotype is linked to markers located in the 4q27-31 region (LOD score 3.10 at recombination fraction 0). Crossover events localize the putative FOP gene within a 36-cM interval bordered proximally by D4S1625 and distally by D4S2417. This interval contains at least one gene involved in the bone morphogenetic protein-signaling pathway.
Collapse
Affiliation(s)
- George Feldman
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Ming Li
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Shelden Martin
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Margrit Urbanek
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - J. Andoni Urtizberea
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Michel Fardeau
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Martine LeMerrer
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - J. Michael Connor
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - James Triffitt
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Roger Smith
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Maximilian Muenke
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Frederick S. Kaplan
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| | - Eileen M. Shore
- Departments of Orthopaedic Surgery, Genetics, Pediatrics, and Medicine, The University of Pennsylvania School of Medicine, Philadelphia; Association Française Contre les Myopathies, Institut de Myologie, and INSERM U 393 Hôpital Necker, Paris; Institute of Medical Genetics, University of Glasgow Medical School, Yorkhill Hospitals, Glasgow; and Bone Research Laboratory, Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford; and Medical Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, MD
| |
Collapse
|